Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17alpha-ethynylestradiol | increases expression | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of LONRF2 mRNA | CTD | PMID:29097150 | 17beta-estradiol | multiple interactions | ISO | LONRF2 (Homo sapiens) | 6480464 | EGF protein promotes the reaction [Estradiol results in increased expression of LONRF2 mRNA] | CTD | PMID:24758408 | 17beta-estradiol | increases expression | ISO | LONRF2 (Homo sapiens) | 6480464 | Estradiol results in increased expression of LONRF2 mRNA | CTD | PMID:23019147 more ... | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | LONRF2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LONRF2 mRNA | CTD | PMID:20106945 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | LONRF2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of LONRF2 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | LONRF2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of LONRF2 mRNA | CTD | PMID:28628672 | 6-propyl-2-thiouracil | decreases expression | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of LONRF2 mRNA | CTD | PMID:30047161 | 6-propyl-2-thiouracil | increases expression | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of LONRF2 mRNA | CTD | PMID:36843608 | aflatoxin B1 | increases methylation | ISO | LONRF2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of LONRF2 gene | CTD | PMID:27153756 | aflatoxin B1 | decreases methylation | ISO | LONRF2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of LONRF2 3' UTR | CTD | PMID:30157460 | all-trans-retinoic acid | increases expression | ISO | LONRF2 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of LONRF2 mRNA | CTD | PMID:23724009 | aluminium atom | decreases expression | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | Aluminum results in decreased expression of LONRF2 mRNA | CTD | PMID:19010380 | aluminium(0) | decreases expression | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | Aluminum results in decreased expression of LONRF2 mRNA | CTD | PMID:19010380 | amitrole | decreases expression | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of LONRF2 mRNA | CTD | PMID:30047161 | benzo[a]pyrene | increases methylation | ISO | LONRF2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of LONRF2 5' UTR and Benzo(a)pyrene results in increased methylation of LONRF2 exon | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | LONRF2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of LONRF2 promoter | CTD | PMID:27901495 | benzo[e]pyrene | increases methylation | ISO | LONRF2 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of LONRF2 intron | CTD | PMID:30157460 | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LONRF2 mRNA | CTD | PMID:31199487 | bisphenol A | decreases expression | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of LONRF2 mRNA | CTD | PMID:25181051 and PMID:30816183 | bisphenol A | increases expression | ISO | LONRF2 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of LONRF2 mRNA | CTD | PMID:36828454 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of LONRF2 mRNA | CTD | PMID:32156529 | bisphenol A | multiple interactions | ISO | LONRF2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] affects the methylation of LONRF2 gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of LONRF2 mRNA | CTD | PMID:29097150 | butanal | decreases expression | ISO | LONRF2 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of LONRF2 mRNA | CTD | PMID:26079696 | Butylbenzyl phthalate | multiple interactions | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LONRF2 mRNA | CTD | PMID:31199487 | CGP 52608 | multiple interactions | ISO | LONRF2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to LONRF2 gene] | CTD | PMID:28238834 | cisplatin | multiple interactions | ISO | LONRF2 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of LONRF2 mRNA | CTD | PMID:27392435 | cisplatin | decreases expression | ISO | LONRF2 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of LONRF2 mRNA | CTD | PMID:27392435 | cyclophosphamide | increases expression | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | Cyclophosphamide results in increased expression of LONRF2 mRNA | CTD | PMID:27281708 | cyclosporin A | increases expression | ISO | LONRF2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of LONRF2 mRNA | CTD | PMID:20106945 and PMID:27989131 | dexamethasone | multiple interactions | ISO | LONRF2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of LONRF2 mRNA | CTD | PMID:28628672 | dibutyl phthalate | multiple interactions | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LONRF2 mRNA | CTD | PMID:31199487 | diethyl phthalate | multiple interactions | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LONRF2 mRNA | CTD | PMID:31199487 | diisobutyl phthalate | multiple interactions | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LONRF2 mRNA | CTD | PMID:31199487 | diisononyl phthalate | multiple interactions | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LONRF2 mRNA | CTD | PMID:31199487 | dioxygen | multiple interactions | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LONRF2 mRNA] and [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LONRF2 mRNA | CTD | PMID:33729688 | doxorubicin | decreases expression | ISO | LONRF2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of LONRF2 mRNA | CTD | PMID:29803840 | epoxiconazole | increases expression | EXP | | 6480464 | epoxiconazole results in increased expression of LONRF2 mRNA | CTD | PMID:35436446 | ethanol | affects splicing | EXP | | 6480464 | Ethanol affects the splicing of LONRF2 mRNA | CTD | PMID:30319688 | fulvestrant | multiple interactions | ISO | LONRF2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] affects the methylation of LONRF2 gene | CTD | PMID:31601247 | indometacin | multiple interactions | ISO | LONRF2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of LONRF2 mRNA | CTD | PMID:28628672 | lead(0) | increases expression | ISO | LONRF2 (Homo sapiens) | 6480464 | Lead results in increased expression of LONRF2 mRNA | CTD | PMID:19921347 | lead(0) | affects expression | ISO | LONRF2 (Homo sapiens) | 6480464 | Lead affects the expression of LONRF2 mRNA | CTD | PMID:28903495 | methapyrilene | increases methylation | ISO | LONRF2 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of LONRF2 intron | CTD | PMID:30157460 | methimazole | decreases expression | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of LONRF2 mRNA | CTD | PMID:30047161 | N,N-diethyl-m-toluamide | multiple interactions | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of LONRF2 gene | CTD | PMID:33148267 | nickel atom | decreases expression | ISO | LONRF2 (Homo sapiens) | 6480464 | Nickel results in decreased expression of LONRF2 mRNA | CTD | PMID:24768652 and PMID:25583101 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of LONRF2 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | LONRF2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of LONRF2 mRNA | CTD | PMID:29067470 | permethrin | multiple interactions | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of LONRF2 gene | CTD | PMID:33148267 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of LONRF2 mRNA | CTD | PMID:20813756 | silver atom | increases expression | EXP | | 6480464 | Silver results in increased expression of LONRF2 mRNA | CTD | PMID:27131904 | silver(0) | increases expression | EXP | | 6480464 | Silver results in increased expression of LONRF2 mRNA | CTD | PMID:27131904 | sodium arsenite | increases expression | ISO | LONRF2 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of LONRF2 mRNA | CTD | PMID:29301061 | torcetrapib | increases expression | ISO | LONRF2 (Homo sapiens) | 6480464 | torcetrapib results in increased expression of LONRF2 mRNA | CTD | PMID:23228038 | trichostatin A | decreases expression | ISO | LONRF2 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of LONRF2 mRNA | CTD | PMID:26705709 | triclosan | increases expression | ISO | LONRF2 (Homo sapiens) | 6480464 | Triclosan results in increased expression of LONRF2 mRNA | CTD | PMID:30510588 | valproic acid | increases methylation | ISO | LONRF2 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of LONRF2 gene | CTD | PMID:29154799 | valproic acid | affects splicing | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | Valproic Acid affects the splicing of LONRF2 mRNA | CTD | PMID:29427782 | valproic acid | decreases expression | ISO | Lonrf2 (Rattus norvegicus) | 6480464 | Valproic Acid results in decreased expression of LONRF2 mRNA | CTD | PMID:29427782 | valproic acid | increases expression | ISO | LONRF2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of LONRF2 mRNA | CTD | PMID:24935251 and PMID:29154799 | valproic acid | affects expression | ISO | LONRF2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of LONRF2 mRNA | CTD | PMID:25979313 | vorinostat | decreases expression | ISO | LONRF2 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of LONRF2 mRNA | CTD | PMID:27188386 | zearalenone | increases expression | ISO | LONRF2 (Homo sapiens) | 6480464 | Zearalenone results in increased expression of LONRF2 mRNA | CTD | PMID:36828454 | |